(Q36821481)

16 August 2017

1 reference

title

Epidemiology, etiology, detection, and treatment of autoantibody-associated congenital heart block in neonatal lupus (English)

1 reference

16 August 2017

0 references

1 reference

1 reference

congenital heart block

1 reference

Deborah M Friedman

1

1 reference

16 August 2017

Ann Rupel

series ordinal

2

1 reference

16 August 2017

Jill P Buyon

series ordinal

3

1 reference

16 August 2017

publication date

1 May 2007

1 reference

Current Rheumatology Reports

16 August 2017

published in

1 reference

16 August 2017

volume

9

1 reference

16 August 2017

issue

2

1 reference

16 August 2017

page(s)

101-108

1 reference

Therapeutic trial of sympathomimetics in three cases of complete heart block in the fetus

16 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-007-0003-4

Treatment of fetal heart block with maternal steroid therapy: case report and review of the literature

21 January 2018

1 reference

12 December 2020

Neonatal lupus erythematosus: results of maternal corticosteroid therapy

1 reference

12 December 2020

Fetal echocardiographic screening of pregnancies of mothers with anti-Ro and/or anti-La antibodies

1 reference

12 December 2020

Induction of neonatal lupus in pups of mice immunized with synthetic peptides derived from amino acid sequences of the serotoninergic 5-HT4 receptor

1 reference

12 December 2020

Prevention of recurrence of congenital heart block with intravenous immunoglobulin and corticosteroid therapy: comment on the editorial by Buyon et al

1 reference

12 December 2020

Pulsed Doppler echocardiographic assessment of the fetal PR interval

1 reference

12 December 2020

Fetal first-degree heart block, or where to set the confidence limit: comment on the article by Sonesson et al

1 reference

12 December 2020

Management with a staged approach of the premature hydropic fetus due to complete congenital heart block

1 reference

12 December 2020

Fetal cardiac function assessed by Doppler myocardial performance index (Tei Index)

1 reference

12 December 2020

Fetal ventricular pacing for hydrops secondary to complete atrioventricular block

1 reference

12 December 2020

Autoantibodies against the serotoninergic 5-HT4 receptor and congenital heart block: a reassessment

1 reference

12 December 2020

Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodies

1 reference

12 December 2020

Cardiac 5-HT(4) serotoninergic receptors, 52kD SSA/Ro and autoimmune-associated congenital heart block.

1 reference

12 December 2020

Use of tissue velocity imaging in the diagnosis of fetal cardiac arrhythmias

1 reference

12 December 2020

Autoantibodies against neonatal heart M1 muscarinic acetylcholine receptor in children with congenital heart block

1 reference

12 December 2020

Use of terbutaline in the treatment of complete heart block in the fetus

1 reference

12 December 2020

A review of congenital heart block

1 reference

12 December 2020

Correlation between electrocardiographic and ultrasonographic time-interval measurements in fetal lamb heart

1 reference

12 December 2020

Autoantibody-associated congenital heart block: outcome in mothers and children

1 reference

12 December 2020

Quantification of the fetal electrocardiogram using averaging technique.

1 reference

12 December 2020

Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus

1 reference

12 December 2020

Obstetric uses of intravenous immunoglobulin: successes, failures, and promises

1 reference

12 December 2020

Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block

1 reference

12 December 2020

Fetal congenital complete heart block: prophylaxis with intravenous gammaglobulin and treatment with dexamethasone

1 reference

12 December 2020

Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis

1 reference

12 December 2020

In vitro metabolism of prednisolone, dexamethasone, betamethasone, and cortisol by the human placenta

1 reference

12 December 2020

Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects

1 reference

12 December 2020

The fetal Doppler mechanical PR interval: a validation study

1 reference

12 December 2020

Immunohistological and serological studies in endomyocardial fibrosis

1 reference

12 December 2020

Intravenous gamma-globulin therapy in myocarditis complicated with complete heart block: Report of one case

1 reference

12 December 2020

Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease

1 reference

12 December 2020

Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies

1 reference

12 December 2020

Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies

1 reference

12 December 2020

Relationship between maternal and neonatal levels of antibodies to 48 kDa SSB(La), 52 kDa SSA(Ro), and 60 kDa SSA(Ro) in pregnancies complicated by congenital heart block

1 reference

12 December 2020

A serologic marker for fetal risk of congenital heart block

1 reference

12 December 2020

Prenatal diagnosis of fetal complete atrioventricular block with QT prolongation and alternating ventricular pacemakers using multi-channel magnetocardiography and current-arrow maps

1 reference

12 December 2020

Identifying an early marker for congenital heart block: when is a long PR interval too long? Comment on the article by Sonesson et al

1 reference

12 December 2020

Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block

1 reference

12 December 2020

Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela

1 reference

12 December 2020

Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study

1 reference

12 December 2020

Successful outcome of pregnancy after treatment of maternal anti-Ro (SSA) antibodies with immunosuppressive therapy and plasmapheresis

1 reference

12 December 2020

Successful pregnancy following steroid therapy and plasma exchange in a woman with anti-Ro (SS-A) antibodies. Case report

1 reference

12 December 2020

Anti-SSA/Ro52 autoantibodies blocking the cardiac 5-HT4 serotoninergic receptor could explain neonatal lupus congenital heart block

1 reference

12 December 2020

Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry

1 reference

12 December 2020

10.1007/S11926-007-0003-4

Identifiers

DOI

1 reference

16 August 2017

1 reference